Clínica Baviera, S.A. (CBAV.MC)
EUR 36.4
(1.11%)
EUR 36.4
(1.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 147.83 Million EUR | -65.65% |
| 2022 | 130.83 Million EUR | 17.04% |
| 2021 | 111.78 Million EUR | 28.69% |
| 2020 | 86.86 Million EUR | -4.81% |
| 2019 | 91.25 Million EUR | 14.82% |
| 2018 | 79.47 Million EUR | 6.07% |
| 2017 | 74.92 Million EUR | 9.88% |
| 2016 | 68.18 Million EUR | 1.18% |
| 2015 | 67.38 Million EUR | 2.62% |
| 2014 | 65.66 Million EUR | 3.18% |
| 2013 | 63.64 Million EUR | -16.55% |
| 2012 | 76.26 Million EUR | 1.46% |
| 2011 | 75.17 Million EUR | 3.63% |
| 2010 | 72.54 Million EUR | 1.53% |
| 2009 | 71.44 Million EUR | 3.12% |
| 2008 | 69.28 Million EUR | 27.7% |
| 2007 | 54.25 Million EUR | 34.37% |
| 2006 | 40.37 Million EUR | 296.19% |
| 2005 | 10.19 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 34.24 Million EUR | -64.29% |
| 2024 Q1 | 49.52 Million EUR | 135.41% |
| 2023 Q3 | 54.31 Million EUR | 87.9% |
| 2023 Q2 | 28.9 Million EUR | -33.61% |
| 2023 Q1 | 43.54 Million EUR | 126.27% |
| 2023 Q4 | 21.03 Million EUR | -61.27% |
| 2023 FY | 44.94 Million EUR | -65.65% |
| 2022 Q2 | 25.74 Million EUR | -31.1% |
| 2022 FY | 130.83 Million EUR | 17.04% |
| 2022 Q4 | 19.24 Million EUR | -60.31% |
| 2022 Q3 | 48.48 Million EUR | 88.36% |
| 2022 Q1 | 37.36 Million EUR | 119.06% |
| 2021 Q1 | 30.13 Million EUR | 87.81% |
| 2021 FY | 111.78 Million EUR | 28.69% |
| 2021 Q4 | 17.05 Million EUR | -59.07% |
| 2021 Q3 | 41.67 Million EUR | 81.84% |
| 2021 Q2 | 22.91 Million EUR | -23.95% |
| 2020 Q4 | 16.04 Million EUR | -50.18% |
| 2020 Q2 | 12.42 Million EUR | -52.54% |
| 2020 FY | 86.86 Million EUR | -4.81% |
| 2020 Q3 | 32.2 Million EUR | 159.21% |
| 2020 Q1 | 26.18 Million EUR | 77.3% |
| 2019 Q3 | 31.97 Million EUR | 59.26% |
| 2019 Q1 | 24.43 Million EUR | 98.93% |
| 2019 Q2 | 20.07 Million EUR | -17.83% |
| 2019 Q4 | 14.76 Million EUR | -53.81% |
| 2019 FY | 91.25 Million EUR | 14.82% |
| 2018 Q1 | 22.54 Million EUR | 90.7% |
| 2018 Q3 | 27.66 Million EUR | 62.97% |
| 2018 FY | 79.47 Million EUR | 6.07% |
| 2018 Q4 | 12.28 Million EUR | -55.61% |
| 2018 Q2 | 16.97 Million EUR | -24.71% |
| 2017 Q2 | 15.68 Million EUR | -26.24% |
| 2017 FY | 74.92 Million EUR | 9.88% |
| 2017 Q4 | 11.82 Million EUR | -54.77% |
| 2017 Q3 | 26.14 Million EUR | 66.65% |
| 2017 Q1 | 21.26 Million EUR | 120.08% |
| 2016 Q1 | 20.26 Million EUR | 108.43% |
| 2016 FY | 68.18 Million EUR | 1.18% |
| 2016 Q4 | 9.66 Million EUR | -60.56% |
| 2016 Q3 | 24.5 Million EUR | 78.15% |
| 2016 Q2 | 13.75 Million EUR | -32.13% |
| 2015 Q4 | 9.72 Million EUR | -59.77% |
| 2015 Q1 | 19.73 Million EUR | 102.33% |
| 2015 Q2 | 13.77 Million EUR | -30.21% |
| 2015 Q3 | 24.16 Million EUR | 75.49% |
| 2015 FY | 67.38 Million EUR | 2.62% |
| 2014 Q4 | 9.75 Million EUR | -58.01% |
| 2014 Q2 | 13.87 Million EUR | -26.28% |
| 2014 Q1 | 18.82 Million EUR | 93.57% |
| 2014 FY | 65.66 Million EUR | 3.18% |
| 2014 Q3 | 23.22 Million EUR | 67.38% |
| 2013 Q1 | 21.57 Million EUR | -9.37% |
| 2013 Q3 | 20.99 Million EUR | 84.95% |
| 2013 Q4 | 9.72 Million EUR | -53.69% |
| 2013 FY | 63.64 Million EUR | -16.55% |
| 2013 Q2 | 11.35 Million EUR | -47.39% |
| 2012 Q2 | 16.6 Million EUR | -24.93% |
| 2012 Q3 | 13.73 Million EUR | -17.25% |
| 2012 FY | 76.26 Million EUR | 1.46% |
| 2012 Q1 | 22.11 Million EUR | 0.0% |
| 2012 Q4 | 23.8 Million EUR | 73.28% |
| 2011 FY | 75.17 Million EUR | 3.63% |
| 2010 FY | 72.54 Million EUR | 1.53% |
| 2009 FY | 71.44 Million EUR | 3.12% |
| 2008 FY | 69.28 Million EUR | 27.7% |
| 2007 FY | 54.25 Million EUR | 34.37% |
| 2006 FY | 40.37 Million EUR | 296.19% |
| 2005 FY | 10.19 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 11.37 Million EUR | -1199.244% |